Biology subjects

Biancalani, T.

Publications and source records attributed to Biancalani, T..

At least 19 recordsLinked to original sources

bioRxiv2026

Virtual phenotypic screening discovers novel scaffolds inhibiting the PI3K/mTOR pathway

Phenotypic drug discovery has yielded many first-in-class small-molecule drugs by discovering modulators of disease phenotypes in physiologically relevant cellular systems. However, high-content phenotypic assays lack the ultra-high-throughput scalability of target-based screens. Recent advances in virtual screening present an opportunity to address this bottleneck, but have been limited to simple phenotypes like viability, restricted to small repurposing libraries, or lack in-depth biological validation. Here, we present PhenoCompass, a multimodal co-embedding model that aligns compound structures and high-content phenotypic imaging to enable virtual phenotypic screening over billion-compound libraries. Following training on the Joint Undertaking in Morphology dataset with more than 100,000 Cell Painting compound profiles, retrospective validation with historical biochemical high-throughput screening data demonstrates that PhenoCompass ranks compounds according to their biochemical target engagement. Leveraging PhenoCompass, we performed a prospective screen of 3.8 billion Enamine REAL compounds for inhibitors of PI3K/mTOR pathway, a critical signaling cascade whose aberrant activation is a common tumor driver. This search identified 11 novel compounds with pathway-consistent Cell Painting readout and diverse scaffolds, a 54-fold enrichment over the training set. Orthogonal validation experiments using a FOXO3A reporter assay and direct kinase inhibition confirmed seven structurally novel inhibitors with distinct mechanisms of action. These results highlight the convergence of diverse molecular target profiles onto a shared morphological pathway signature and establish PhenoCompass as a robust framework for high-content phenotypic virtual screening.

bioinformatics↗

bioRxiv2026

SCALLOPS: a scalable, integrated computational framework for Optical Pooled Screens

Optical pooled screens (OPS) link pooled genetic perturbations to high-dimensional image-based phenotypes at scale, but their widespread adoption is hindered by computational bottlenecks in processing terabyte-scale, multimodal image data. We present SCALLOPS, a unified, modular, and cloud-native computational framework that overcomes these bottlenecks. SCALLOPS implements a "well-centric" processing strategy that integrates robust stitching with a non-linear two-stage registration strategy, enabling accurate alignment of multi-magnification images, reliable single-cell genotype-phenotype linkage, and efficient morphological feature extraction. Benchmarking with public and newly-generated datasets demonstrated SCALLOPS superior performance over existing solutions. Crucially, SCALLOPS uniquely enables robust processing of 4x magnification in situ sequencing data, accelerating image acquisition by around six-fold. We applied SCALLOPS to an optical pooled screen investigating the estrogen receptor (ER) degrader vepdegestrant in a breast cancer cell line, successfully recovering its known mechanism of action, highlighting the value of OPS in translational research. SCALLOPS provides a scalable end-to-end solution, making large-scale OPS routine.

bioinformatics↗

bioRxiv2026

Linking live-cell behavior to transcriptional responses across perturbations using dynamic caging

Single-cell technologies, encompassing molecular, morphological, and functional assays, have emerged as cornerstones of modern biological research and discovery. However, current experimental methods often fail to explicitly link these omic modalities, especially in live cells or longitudinally through time, impeding the study of multi-scale interactions and mechanisms of regulation. CellCage Enclosure (CCE) technology overcomes these limitations by dynamically compartmentalizing cells, allowing for scalable, live-cell, longitudinal exploration and simultaneous analysis of transcriptomic, proteomic, and morphological profiles. Using this novel technology, we generate previously inaccessible insights across various in vitro cellular systems under a diverse set of perturbations, including the discovery of morphological and proteomic features linked to immune suppressive gene set expression in human primary regulatory T cells (Tregs), as well as direct association of morphological and proteomic features with inflammatory gene modules in human colonic fibroblasts. We then develop a novel pooled CRISPR genetic screening technology using CCEs, PERTURB-LINK (PERTURBational LINKage of transcriptomics and imaging in single cells via enclosure-based screening) and apply this approach in murine bone marrow derived macrophages (BMDMs), enabling multiomic dissection of NF-{kappa}B pathway regulation in response to lipopolysaccharide (LPS) stimulation. Together, these findings demonstrate the broad impact that advancements in live-cell, paired multimodal technologies, especially upon perturbation, may offer in deepening our understanding of cellular biology.

cell biology↗

bioRxiv2026

TxConformal: Controlling False Discoveries in AI-Driven Therapeutic Discovery

Artificial Intelligence (AI) is transforming therapeutic discovery by scoring a large set of promising candidates and prioritizing a shortlist for further investigation. Quantifying the reliability of AI scores and preventing false positives among selected candidates is key to the efficiency of the discovery process. Conformal prediction (CP) has emerged as a popular tool for guiding such prioritization, especially via the conformal selection framework to control false discovery rates (FDR) in selecting top-ranked candidates under distributional shift1, 2. However, deploying these advances in real-world therapeutic discovery remains challenging: distribution shifts are difficult to quantify and correct in high-dimensional biomedical data, and practical workflows often require flexible error metrics. Here, we present TO_SCPLOWXC_SCPLOWCO_SCPLOWONFORMALC_SCPLOW, a general framework for trustworthy decision making when building shortlists using AI scores. TO_SCPLOWXC_SCPLOWCO_SCPLOWONFORMALC_SCPLOW adjusts for distribution shift by balancing the hidden representations in AI models and then provides confidence measures for true discoveries of target biological properties. These confidence measures, interpretable as p-values, can be used in conjunction with statistical multiple testing procedures to derive selection decisions with limited false positives or to estimate the errors in given selection decisions. TO_SCPLOWXC_SCPLOWCO_SCPLOWONFORMALC_SCPLOW controls the false positive rate in six real-world tasks spanning various therapeutic discovery stages, modalities, and AI models with realistic data splits. When selecting promising combinatorial genetic perturbations, TO_SCPLOWXC_SCPLOWCO_SCPLOWONFORMALC_SCPLOW nearly halves false-positive selections compared to baseline methods, substantially reducing unnecessary experimental costs by tens of thousands of dollars. When selecting stable protein structures under mutant shifts, TO_SCPLOWXC_SCPLOWCO_SCPLOWONFORMALC_SCPLOW identifies about 10 times more proteins than baseline methods at stringent thresholds when running at a target FDR level of 10%, recovering over 90% of valuable candidates that baseline methods miss due to unaccounted distribution shifts. Furthermore, we demonstrate that TO_SCPLOWXC_SCPLOWCO_SCPLOWONFORMALC_SCPLOW robustly supports various alternative error metrics suitable for resource-constrained settings. Finally, in a prospective fixed-budget virtual screening campaign for novel antibiotic discovery, TO_SCPLOWXC_SCPLOWCO_SCPLOWONFORMALC_SCPLOW predicted false positives in close agreement with experimental outcomes, with substantial improvements over simple baselines.

bioinformatics↗

bioRxiv2026

Spatial Decoding of Tertiary Lymphoid Structure Maturation in Non-Small Cell Lung Cancer Using Deep Neural Networks

Understanding the role of tertiary lymphoid structures (TLS) is crucial in non-small cell lung cancer (NSCLC), as they are associated with patient prognosis and treatment outcomes. Specific cellular ecosystems that originate anti-tumor activity or predict immunotherapy response remain poorly characterized. To this end, we developed a high-resolution, multimodal spatial atlas jointly profiling transcriptomics, proteomics, and histology to characterize TLS maturation in NSCLC alongside secondary lymph organs as a baseline. Using this atlas, we proposed a pathologist-in-the-loop framework that combines a variational graph autoencoder (VGAE) with diffusion pseudotime to refine human expert annotations and characterize TLS maturation. These spatial molecular representations were extended to H&E whole-slide images via a vision transformer-based foundation model. Next, we resolved cellular composition, spatial organization, and cell-cell interactions within these data and defined two divergent spatial ecosystems. Clinical evidence suggests that these ecosystems are associated with distinct patient outcomes: a mature germinal center niche with favorable prognoses, and a tumor-macrophage-fibroblast niche with unfavorable prognoses. In summary, our work decodes key components of TLS heterogeneity, identifies hallmark spatial patterns involved in NSCLC adaptive immunity, and provides a framework for translating spatial omics insights into clinical applications.

genomics↗

bioRxiv2025

Nona: A unifying multimodal masking framework for functional genomics

The non-coding genome encodes complex regulatory logic that orchestrates gene expression and cell identity. While machine learning models for functional genomics have advanced our understanding of the cis-regulatory code, sequence-to-function models, DNA language models, and generative models have evolved as separate paradigms despite probing the same underlying regulatory biology. We introduce Nona, a multimodal masked modeling framework that unifies these paradigms by learning jointly from DNA sequence and base-resolution functional genomics data. Beyond unifying existing modeling paradigms, Nona enables entirely new modeling objectives. We demonstrate its versatility through three applications: (1) a context-aware sequence-to-function model that improves local predictions by up to 13% by correcting systematic errors in sequence-to-function predictions; (2) a functional language model that integrates functional data into language modeling, learns relevant regulatory sequence motifs, and enables regulatory element design through masked discrete diffusion; (3) functional genotyping, which reveals an unrecognized privacy vulnerability in processed ATAC-seq data and re-identifies individuals from genetic databases with perfect accuracy. Together, these results establish masking as a universal interface for integrated modeling of functional genomics data, unifying disparate approaches while opening new directions for understanding and engineering the regulatory genome.

genomics↗

bioRxiv2025

Inferring cellular communication through mapping cells in space using Tangram 2

Cell-to-cell communication (CCC) shapes development, immunity, and disease, yet current spatial transcriptomics (SRT) platforms rarely achieve both single-cell resolution and high-quality transcriptome-wide coverage to accurately characterize CCC in the tissue microenvironment. Tangram2 bridges this gap by integrating single-cell RNA sequencing (scRNA-seq) with SRT to identify genes whose expression changes as a function of neighboring cell types. By accurately mapping cells in tissue space, Tangram2 disentangles interaction-driven transcriptional shifts from intrinsic identity markers, yielding mechanistic CCC maps. Validation across diverse settings--including Slide-tags, co-cultured experiments, human lymph nodes, and simulations--demonstrates high accuracy. Applied to triple-negative breast cancer (TNBC) and cutaneous squamous cell carcinoma (cSCC), Tangram2 recapitulates known biology and uncovers new hypotheses, including various immunosuppressive mechanisms in TNBC and a macrophage-regulatory T-cell circuit associated with survival in cSCC.

genomics↗

bioRxiv2025

Deep Evolutionary Fitness Inference for Variant Nomination from Directed Evolution

Iterative screening techniques, such as directed evolution, enable high-throughput affinity maturation to optimize binders to molecular interfaces. However, the decision problem of selecting variants from rich, evolved populations to enter low-throughput follow-up methods remains a significant bottleneck. Here, we present evolutionary fitness inference (EVFI) and DeepEVFI, two machine learning methods that model directed evolution from time-series sequencing data, and infer fitness, a variants ability to enrich under selection pressure. Our methods flexibly handle mutation mechanisms and starting populations that may be partially unknown - settings relevant to drug discovery - and achieve strong performance on a diverse set of experimental data. We conducted two experimental directed evolution campaigns, using antibodies and macrocyclic peptides libraries to identify and optimize binders to therapeutically relevant targets. EVFI and DeepEVFI identified tighter binders that were missed by human experts using conventional frequency-based approaches, including "rising stars" with low frequency. Beyond initial hit discovery, EVFI and Deep-EVFI enables labeling large-scale sequence-fitness datasets and identifying variants of initial binders with diverse properties.

bioinformatics↗

bioRxiv2025

Foundation Model Attributions Reveal Shared Inflammatory Program Across Diseases

Determining a genes functional significance within a cellular context has long been a challenge, as absolute expression level is an unreliable indicator. We introduce SIGnature, a framework for scoring gene importance by leveraging attributions derived from single-cell RNA-sequencing (scRNA-seq) foundation models. Attribution scores reduce technical noise, emphasize regulatory genes, and facilitate cross-dataset comparison - a core challenge for scRNA-seq analyses. We developed the SIGnature package as a tool for generating and querying attributions, enabling rapid gene set searches across massive scRNA-seq atlases. We demonstrated its utility using the MS1 monocyte signature, a poorly understood gene program activated in severe COVID-19 and sepsis. Searching 400 studies revealed novel associations between the MS1 signature and multiple hyperinflammatory conditions, including Kawasaki disease. Experimental validation confirmed Kawasaki disease patient serum induces the MS1 phenotype. These findings highlight that SIGnature can uncover shared mechanisms across conditions, demonstrating its power for large-scale signature scoring and cross-disease analysis.

bioinformatics↗

bioRxiv2025

Gene-embedding-based prediction and functional evaluation of perturbation expression responses with PRESAGE

Understanding the impact of genetic perturbations on cellular behavior is crucial for biological research, but comprehensive experimental mapping remains infeasible. We introduce PRESAGE (Perturbation Response EStimation with Aggregated Gene Embeddings), a simple, modular, and interpretable framework that predicts perturbation-induced expression changes by integrating diverse knowledge sources via gene embeddings. PRESAGE transforms gene embeddings through an attention-based model to predict perturbation expression outcomes. To assess model performance, we introduce a comprehensive evaluation suite with novel functional metrics that move beyond traditional regression tasks, including measures of accuracy in effect size prediction, in identifying perturbations with similar expression profiles (phenocopy), and in prediction of perturbations with the strongest impact on specific gene set scores. PRESAGE outperforms existing methods in both classical regression metrics and our novel functional evaluations. Through ablation studies, we demonstrate that knowledge source selection is more critical for predictive performance than architectural complexity, with cross-system Perturb-seq data providing particularly strong predictive power. We also find that performance saturates quickly with training set size, suggesting that experimental design strategies might benefit from collecting sparse perturbation data across multiple biological systems rather than exhaustive profiling of individual systems. Overall, PRESAGE establishes a robust framework for advancing perturbation response prediction and facilitating the design of targeted biological experiments, significantly improving our ability to predict cellular responses across diverse biological systems.

bioinformatics↗

bioRxiv2024

Decoding sequence determinants of gene expression in diverse cellular and disease states

Sequence-to-function models that predict gene expression from genomic DNA sequence have proven valuable for many biological tasks, including understanding cis-regulatory syntax and interpreting non-coding genetic variants. However, current state-of-the-art models have been trained largely on bulk expression profiles from healthy tissues or cell lines, and have not learned the properties of precise cell types and states that are captured in large-scale single-cell transcriptomic datasets. Thus, they lack the ability to perform these tasks at the resolution of specific cell types or states across diverse tissue and disease contexts. To address this gap, we present Decima, a model that predicts the cell type- and condition- specific expression of a gene from its surrounding DNA sequence. Decima is trained on single-cell or single-nucleus RNA sequencing data from over 22 million cells, and successfully predicts the cell type-specific expression of unseen genes based on their sequence alone. Here, we demonstrate Decimas ability to reveal the cis-regulatory mechanisms driving cell type-specific gene expression and its changes in disease, to predict non-coding variant effects at cell type resolution, and to design regulatory DNA elements with precisely tuned, context-specific functions.

genomics↗

bioRxiv2024

gReLU: A comprehensive framework for DNA sequence modeling and design

Deep learning models are increasingly being used to perform a variety of tasks on DNA sequences, such as predicting tissue- and cell type-specific sequence activity, deriving cis-regulatory rules, predicting non-coding variant effects, and designing synthetic regulatory sequences. However, these models require specialized knowledge to build, train and interpret correctly. In addition, the field is hampered by the lack of interoperability between models and software built by different groups. Here we present gReLU, a comprehensive software framework that enables users to easily execute advanced sequence modeling pipelines, including data preprocessing, model training, hyperparameter tuning, evaluation, interpretation, variant effect prediction, and design of novel regulatory elements. The software is accompanied by a model zoo containing state-of-the-art pre-trained models that can easily be downloaded, applied, and fine-tuned. This framework and resources will accelerate research across the field of DNA sequence modeling and enable the effective design of synthetic regulatory elements.

genomics↗

bioRxiv2024

A high-throughput phenotypic screen combined with an ultra-large-scale deep learning-based virtual screening reveals novel scaffolds of antibacterial compounds

The proliferation of multi-drug-resistant bacteria underscores an urgent need for novel antibiotics. Traditional discovery methods face challenges due to limited chemical diversity, high costs, and difficulties in identifying structurally novel compounds. Here, we explore the integration of small molecule high-throughput screening with a deep learning-based virtual screening approach to uncover new antibacterial compounds. Leveraging a diverse library of nearly 2 million small molecules, we conducted comprehensive phenotypic screening against a sensitized Escherichia coli strain that, at a low hit rate, yielded thousands of hits. We trained a deep learning model, GNEprop, to predict antibacterial activity, ensuring robustness through out-of-distribution generalization techniques. Virtual screening of over 1.4 billion compounds identified potential candidates, of which 82 exhibited antibacterial activity, illustrating a 90X improved hit rate over the high-throughput screening experiment GNEprop was trained on. Importantly, a significant portion of these newly identified compounds exhibited high dissimilarity to known antibiotics, indicating promising avenues for further exploration in antibiotic discovery.

bioinformatics↗

bioRxiv2024

Fibroblastic FLT3L supports lymph node dendritic cells in the interfollicular niche

Dendritic cell (DC) homeostasis is maintained in secondary lymphoid organs (SLOs) by Fms-like tyrosine kinase 3 ligand (FLT3L). The specific niche providing this DC growth factor within human and mouse SLOs is unclear. Here, we show that Gremlin1 (Grem1)-expressing lymph node fibroblastic reticular cells (FRCs) support DC homeostasis via provision of FLT3L. Grem1 FRCs co-localize with DCs and express FLT3L in human and mouse lymph nodes. Using a new genetic model, we provide evidence that FLT3L produced by GREM1 FRCs maintains lymph node preDCs, cDCs, and plasmacytoid DCs (pDCs). Spatial transcriptomics and cytofluorometry reveal that Grem1 FRC-derived FLT3L supports not only proliferation, but also survival of lymph node cDCs within the interfollicular zone (IFZ). Functionally, loss of Grem1 FRC-derived FLT3L impairs cDC priming of antigen-specific T cell responses. These findings provide key mechanistic insights underlying stromal cell support of DC homeostasis and function.

immunology↗

bioRxiv2024

regLM: Designing realistic regulatory DNA with autoregressive language models

Cis-regulatory elements (CREs), such as promoters and en-hancers, are DNA sequences that regulate the expression of genes. The activity of a CRE is influenced by the order, composition and spacing of sequence motifs that bind to proteins called transcription factors (TFs). Synthetic CREs with specific properties are needed for biomanufacturing as well as for many therapeutic applications including cell and gene therapy. Here, we present regLM, a framework to design synthetic CREs with desired properties, such as high, low or cell type-specific activity, using autoregressive language models in conjunction with supervised sequence-to-function models. We used our framework to design synthetic yeast promoters and cell type-specific human enhancers. We demonstrate that the synthetic CREs generated by our approach are not only predicted to have the desired functionality but also contain biological features similar to experimentally validated CREs. regLM thus facilitates the design of realistic regulatory DNA elements while providing insights into the cis-regulatory code.

genomics↗

bioRxiv2023

Polygraph: A Software Framework for the Systematic Assessment of Synthetic Regulatory DNA Elements

The design of regulatory elements is pivotal in gene and cell therapy, where DNA sequences are engineered to drive elevated and cell-type specific expression. However, the systematic assessment of synthetic DNA sequences without robust metrics and easy-to-use software remains challenging. Here, we introduce Polygraph, a Python framework that evaluates synthetic DNA elements, based on features like diversity, motif and k-mer composition, similarity to endogenous sequences, and screening with predictive and foundational models. Polygraph is the first instrument for assessing synthetic regulatory sequences, enabling faster progress in therapeutic interventions and improving our understanding of gene regulatory mechanisms.

bioinformatics↗

bioRxiv2023

Scalable querying of human cell atlases via a foundational model reveals commonalities across fibrosis-associated macrophages

Single-cell RNA-seq (scRNA-seq) studies have profiled over 100 million human cells across diseases, developmental stages, and perturbations to date. A singular view of this vast and growing expression landscape could help reveal novel associations between cell states and diseases, discover cell states in unexpected tissue contexts, and relate in vivo cells to in vitro models. However, these require a common, scalable representation of cell profiles from across the body, a general measure of their similarity, and an efficient way to query these data. Here, we present SCimilarity, a metric learning framework to learn and search a unified and interpretable representation that annotates cell types and instantaneously queries for a cell state across tens of millions of profiles. We demonstrate SCimilarity on a 22.7 million cell corpus assembled across 399 published scRNA-seq studies, showing accurate integration, annotation and querying. We experimentally validated SCimilarity by querying across tissues for a macrophage subset originally identified in interstitial lung disease, and showing that cells with similar profiles are found in other fibrotic diseases, tissues, and a 3D hydrogel system, which we then repurposed to yield this cell state in vitro. SCimilarity serves as a foundational model for single cell gene expression data and enables researchers to query for similar cellular states across the entire human body, providing a powerful tool for generating novel biological insights from the growing Human Cell Atlas.

bioinformatics↗

bioRxiv2022

Biological Cartography: Building and Benchmarking Representations of Life

1The continued scaling of genetic perturbation technologies combined with high-dimensional assays such as cellular microscopy and RNA-sequencing has enabled genome-scale reverse-genetics experiments that go beyond single-endpoint measurements of growth or lethality. Datasets emerging from these experiments can be combined to construct perturbative "maps of biology", in which readouts from various manipulations (e.g., CRISPR-Cas9 knockout, CRISPRi knockdown, compound treatment) are placed in unified, relatable embedding spaces allowing for the generation of genome-scale sets of pairwise comparisons. These maps of biology capture known biological relationships and uncover new associations which can be used for downstream discovery tasks. Construction of these maps involves many technical choices in both experimental and computational protocols, motivating the design of benchmark procedures to evaluate map quality in a systematic, unbiased manner. Here, we (1) establish a standardized terminology for the steps involved in perturbative map building, (2) introduce key classes of benchmarks to assess the quality of such maps, (3) construct maps from four genome-scale datasets employing different cell types, perturbation technologies, and data readout modalities, (4) generate benchmark metrics for the constructed maps and investigate the reasons for performance variations, and (5) demonstrate utility of these maps to discover new biology by suggesting roles for two largely uncharacterized genes. 2 Author SummaryWith the proliferation of genetic perturbation, laboratory robotics, computer vision and sequencing technologies, a growing number of researchers are producing datasets that capture digital readouts of cellular responses to genetic perturbations at the full-genome-scale. Since each of these efforts utilizes different cellular models, experimental approaches, terminology, code bases, analysis methods and quality metrics, it is exceptionally difficult to reason through the pros and cons of possible design choices or even discuss the primary considerations when embarking on such an endeavor. These datasets can be powerful discovery tools to look at known biological relationships and uncover new associations in an unbiased manner, but only when paired with a computational pipeline to assemble the data into a digestible format. Moreover, there is great promise in looking across these data to highlight commonalities and differences that may be attributed to experimental or analytical approaches or the biological context. Therefore, a unified framework is necessary to align this nascent field and speed progress in assessing technologies and methods. In this work we define a unified framework for building and benchmarking these perturbative maps, benchmark four different datasets assembled into 18 different maps, explore the impact of different design decisions and demonstrate how these maps can be used to elucidate gene functions. The framework we propose highlights the necessary steps for building any such map - embedding, filtering, aligning, aggregating and relating the data across perturbations. For benchmarking, we propose two main types of metrics and give examples which highlight the impact of different processing pipelines. Finally, we explore these maps to demonstrate their utility for confirming known biological relationships and nominating annotations for genes with unknown function. We expect that this work will positively impact the nascent field of perturbative map building by enabling easier comparisons within and between technologies and methods through a shared language. Additionally, the associated code base is openly available and flexible enough to be easily extended with new methods, so we hope that it will become a resource for future researchers working on developing both laboratory and computational methodology. While there are too many confounding variables to make recommendations on the strengths of different technologies and cellular models at this time, highlighting that fact may prompt studies designed with the goal of directly comparing methods while holding other confounding variables fixed. Moreover, as the number of perturbative maps grows, the field will naturally consider the advantages of combining maps across modalities and the framework provided here can also help guide the evaluation of those efforts.

bioinformatics↗